UK markets open in 21 minutes
  • NIKKEI 225

    29,538.73
    -229.33 (-0.77%)
     
  • HANG SENG

    28,439.49
    -259.31 (-0.90%)
     
  • CRUDE OIL

    59.06
    -0.26 (-0.44%)
     
  • GOLD FUTURES

    1,740.20
    -4.60 (-0.26%)
     
  • DOW

    33,800.60
    +297.00 (+0.89%)
     
  • BTC-GBP

    44,070.96
    +287.99 (+0.66%)
     
  • CMC Crypto 200

    1,291.81
    +64.27 (+5.24%)
     
  • ^IXIC

    13,900.19
    +70.89 (+0.51%)
     
  • ^FTAS

    3,949.51
    -11.46 (-0.29%)
     

Implantable Drug Delivery Devices Market to Reach $30.2 Billion by 2027

ReportLinker
·27-min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 7. - Influencer Pool: 7172. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, April 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Implantable Drug Delivery Devices Industry" - https://www.reportlinker.com/p05960990/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Implantable Drug Delivery Devices Market to Reach $30.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Implantable Drug Delivery Devices estimated at US$20 Billion in the year 2020, is projected to reach a revised size of US$30.2 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Contraceptive Implants, one of the segments analyzed in the report, is projected to record a 6.3% CAGR and reach US$7.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Spinal Implants segment is readjusted to a revised 5.7% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $5.9 Billion, While China is Forecast to Grow at 5.7% CAGR
- The Implantable Drug Delivery Devices market in the U.S. is estimated at US$5.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.
- Brachytherapy Seeds Segment to Record 6.1% CAGR
- In the global Brachytherapy Seeds segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$920.1 Million in the year 2020 will reach a projected size of US$1.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.5 Billion by the year 2027.

- Select Competitors (Total 46 Featured) -

  • Abbott Laboratories

  • Allergan PLC

  • Bausch and Lomb, Inc.

  • Bayer AG

  • Boston Scientific Corporation

  • Medtronic PLC

  • Merck & Co., Inc.

  • Teleflex, Inc.

  • Varian Medical Systems, Inc.




Read the full report: https://www.reportlinker.com/p05960990/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Implantable Drug
Delivery Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Implantable Drug Delivery
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 3: World 15-Year Perspective for Implantable Drug
Delivery Devices by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Contraceptive
Implants by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 5: World Historic Review for Contraceptive Implants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Contraceptive Implants
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Spinal Implants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Spinal Implants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Spinal Implants by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Brachytherapy
Seeds by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Brachytherapy Seeds by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Brachytherapy Seeds by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Drug Eluting
Stents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 14: World Historic Review for Drug Eluting Stents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Drug Eluting Stents by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Bio-absorbable
Stents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Bio-absorbable Stents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Bio-absorbable Stents
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Intraocular
Implants by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: World Historic Review for Intraocular Implants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Intraocular Implants by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Infusion Pumps by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Infusion Pumps by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Infusion Pumps by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other Product
Types by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Other Product Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Other Product Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Biodegradable by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Biodegradable by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Biodegradable by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Non-biodegradable
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 32: World Historic Review for Non-biodegradable by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Non-biodegradable by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Diffusion by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 35: World Historic Review for Diffusion by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Diffusion by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 37: World Current & Future Analysis for Osmotic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 38: World Historic Review for Osmotic by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 39: World 15-Year Perspective for Osmotic by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 40: World Current & Future Analysis for Magnetic by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 41: World Historic Review for Magnetic by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 42: World 15-Year Perspective for Magnetic by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 43: World Current & Future Analysis for Other
Technologies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 44: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 45: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 46: World Current & Future Analysis for Contraception by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 47: World Historic Review for Contraception by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 48: World 15-Year Perspective for Contraception by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 49: World Current & Future Analysis for Ophthalmology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 50: World Historic Review for Ophthalmology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 51: World 15-Year Perspective for Ophthalmology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 52: World Current & Future Analysis for Cardiovascular by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 53: World Historic Review for Cardiovascular by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 54: World 15-Year Perspective for Cardiovascular by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 55: World Current & Future Analysis for Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 56: World Historic Review for Diabetes by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 57: World 15-Year Perspective for Diabetes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 58: World Current & Future Analysis for Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 59: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 60: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 61: World Current & Future Analysis for Autoimmune
Diseases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 62: World Historic Review for Autoimmune Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 63: World 15-Year Perspective for Autoimmune Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 64: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 65: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 66: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 67: USA Current & Future Analysis for Implantable Drug
Delivery Devices by Product Type - Contraceptive Implants,
Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 68: USA Historic Review for Implantable Drug Delivery
Devices by Product Type - Contraceptive Implants, Spinal
Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 69: USA 15-Year Perspective for Implantable Drug Delivery
Devices by Product Type - Percentage Breakdown of Value Sales
for Contraceptive Implants, Spinal Implants, Brachytherapy
Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular
Implants, Infusion Pumps and Other Product Types for the Years
2012, 2020 & 2027

Table 70: USA Current & Future Analysis for Implantable Drug
Delivery Devices by Type - Biodegradable and Non-biodegradable -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 71: USA Historic Review for Implantable Drug Delivery
Devices by Type - Biodegradable and Non-biodegradable Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 72: USA 15-Year Perspective for Implantable Drug Delivery
Devices by Type - Percentage Breakdown of Value Sales for
Biodegradable and Non-biodegradable for the Years 2012, 2020 &
2027

Table 73: USA Current & Future Analysis for Implantable Drug
Delivery Devices by Technology - Diffusion, Osmotic, Magnetic
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 74: USA Historic Review for Implantable Drug Delivery
Devices by Technology - Diffusion, Osmotic, Magnetic and Other
Technologies Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 75: USA 15-Year Perspective for Implantable Drug Delivery
Devices by Technology - Percentage Breakdown of Value Sales for
Diffusion, Osmotic, Magnetic and Other Technologies for the
Years 2012, 2020 & 2027

Table 76: USA Current & Future Analysis for Implantable Drug
Delivery Devices by Application - Contraception, Ophthalmology,
Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and
Other Applications - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 77: USA Historic Review for Implantable Drug Delivery
Devices by Application - Contraception, Ophthalmology,
Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 78: USA 15-Year Perspective for Implantable Drug Delivery
Devices by Application - Percentage Breakdown of Value Sales
for Contraception, Ophthalmology, Cardiovascular, Diabetes,
Oncology, Autoimmune Diseases and Other Applications for the
Years 2012, 2020 & 2027

CANADA
Table 79: Canada Current & Future Analysis for Implantable Drug
Delivery Devices by Product Type - Contraceptive Implants,
Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 80: Canada Historic Review for Implantable Drug Delivery
Devices by Product Type - Contraceptive Implants, Spinal
Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 81: Canada 15-Year Perspective for Implantable Drug
Delivery Devices by Product Type - Percentage Breakdown of
Value Sales for Contraceptive Implants, Spinal Implants,
Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable
Stents, Intraocular Implants, Infusion Pumps and Other Product
Types for the Years 2012, 2020 & 2027

Table 82: Canada Current & Future Analysis for Implantable Drug
Delivery Devices by Type - Biodegradable and Non-biodegradable -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 83: Canada Historic Review for Implantable Drug Delivery
Devices by Type - Biodegradable and Non-biodegradable Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 84: Canada 15-Year Perspective for Implantable Drug
Delivery Devices by Type - Percentage Breakdown of Value Sales
for Biodegradable and Non-biodegradable for the Years 2012,
2020 & 2027

Table 85: Canada Current & Future Analysis for Implantable Drug
Delivery Devices by Technology - Diffusion, Osmotic, Magnetic
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 86: Canada Historic Review for Implantable Drug Delivery
Devices by Technology - Diffusion, Osmotic, Magnetic and Other
Technologies Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 87: Canada 15-Year Perspective for Implantable Drug
Delivery Devices by Technology - Percentage Breakdown of Value
Sales for Diffusion, Osmotic, Magnetic and Other Technologies
for the Years 2012, 2020 & 2027

Table 88: Canada Current & Future Analysis for Implantable Drug
Delivery Devices by Application - Contraception, Ophthalmology,
Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and
Other Applications - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 89: Canada Historic Review for Implantable Drug Delivery
Devices by Application - Contraception, Ophthalmology,
Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 90: Canada 15-Year Perspective for Implantable Drug
Delivery Devices by Application - Percentage Breakdown of Value
Sales for Contraception, Ophthalmology, Cardiovascular,
Diabetes, Oncology, Autoimmune Diseases and Other Applications
for the Years 2012, 2020 & 2027

JAPAN
Table 91: Japan Current & Future Analysis for Implantable Drug
Delivery Devices by Product Type - Contraceptive Implants,
Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 92: Japan Historic Review for Implantable Drug Delivery
Devices by Product Type - Contraceptive Implants, Spinal
Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 93: Japan 15-Year Perspective for Implantable Drug
Delivery Devices by Product Type - Percentage Breakdown of
Value Sales for Contraceptive Implants, Spinal Implants,
Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable
Stents, Intraocular Implants, Infusion Pumps and Other Product
Types for the Years 2012, 2020 & 2027

Table 94: Japan Current & Future Analysis for Implantable Drug
Delivery Devices by Type - Biodegradable and Non-biodegradable -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 95: Japan Historic Review for Implantable Drug Delivery
Devices by Type - Biodegradable and Non-biodegradable Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 96: Japan 15-Year Perspective for Implantable Drug
Delivery Devices by Type - Percentage Breakdown of Value Sales
for Biodegradable and Non-biodegradable for the Years 2012,
2020 & 2027

Table 97: Japan Current & Future Analysis for Implantable Drug
Delivery Devices by Technology - Diffusion, Osmotic, Magnetic
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 98: Japan Historic Review for Implantable Drug Delivery
Devices by Technology - Diffusion, Osmotic, Magnetic and Other
Technologies Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 99: Japan 15-Year Perspective for Implantable Drug
Delivery Devices by Technology - Percentage Breakdown of Value
Sales for Diffusion, Osmotic, Magnetic and Other Technologies
for the Years 2012, 2020 & 2027

Table 100: Japan Current & Future Analysis for Implantable Drug
Delivery Devices by Application - Contraception, Ophthalmology,
Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and
Other Applications - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 101: Japan Historic Review for Implantable Drug Delivery
Devices by Application - Contraception, Ophthalmology,
Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 102: Japan 15-Year Perspective for Implantable Drug
Delivery Devices by Application - Percentage Breakdown of Value
Sales for Contraception, Ophthalmology, Cardiovascular,
Diabetes, Oncology, Autoimmune Diseases and Other Applications
for the Years 2012, 2020 & 2027

CHINA
Table 103: China Current & Future Analysis for Implantable Drug
Delivery Devices by Product Type - Contraceptive Implants,
Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 104: China Historic Review for Implantable Drug Delivery
Devices by Product Type - Contraceptive Implants, Spinal
Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 105: China 15-Year Perspective for Implantable Drug
Delivery Devices by Product Type - Percentage Breakdown of
Value Sales for Contraceptive Implants, Spinal Implants,
Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable
Stents, Intraocular Implants, Infusion Pumps and Other Product
Types for the Years 2012, 2020 & 2027

Table 106: China Current & Future Analysis for Implantable Drug
Delivery Devices by Type - Biodegradable and Non-biodegradable -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 107: China Historic Review for Implantable Drug Delivery
Devices by Type - Biodegradable and Non-biodegradable Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 108: China 15-Year Perspective for Implantable Drug
Delivery Devices by Type - Percentage Breakdown of Value Sales
for Biodegradable and Non-biodegradable for the Years 2012,
2020 & 2027

Table 109: China Current & Future Analysis for Implantable Drug
Delivery Devices by Technology - Diffusion, Osmotic, Magnetic
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: China Historic Review for Implantable Drug Delivery
Devices by Technology - Diffusion, Osmotic, Magnetic and Other
Technologies Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 111: China 15-Year Perspective for Implantable Drug
Delivery Devices by Technology - Percentage Breakdown of Value
Sales for Diffusion, Osmotic, Magnetic and Other Technologies
for the Years 2012, 2020 & 2027

Table 112: China Current & Future Analysis for Implantable Drug
Delivery Devices by Application - Contraception, Ophthalmology,
Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and
Other Applications - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 113: China Historic Review for Implantable Drug Delivery
Devices by Application - Contraception, Ophthalmology,
Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 114: China 15-Year Perspective for Implantable Drug
Delivery Devices by Application - Percentage Breakdown of Value
Sales for Contraception, Ophthalmology, Cardiovascular,
Diabetes, Oncology, Autoimmune Diseases and Other Applications
for the Years 2012, 2020 & 2027

EUROPE
Table 115: Europe Current & Future Analysis for Implantable
Drug Delivery Devices by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 116: Europe Historic Review for Implantable Drug Delivery
Devices by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 117: Europe 15-Year Perspective for Implantable Drug
Delivery Devices by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 118: Europe Current & Future Analysis for Implantable
Drug Delivery Devices by Product Type - Contraceptive Implants,
Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 119: Europe Historic Review for Implantable Drug Delivery
Devices by Product Type - Contraceptive Implants, Spinal
Implants, Brachytherapy Seeds, Drug Eluting Stents,
Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and
Other Product Types Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 120: Europe 15-Year Perspective for Implantable Drug
Delivery Devices by Product Type - Percentage Breakdown of
Value Sales for Contraceptive Implants, Spinal Implants,
Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable
Stents, Intraocular Implants, Infusion Pumps and Other Product
Types for the Years 2012, 2020 & 2027

Table 121: Europe Current & Future Analysis for Implantable
Drug Delivery Devices by Type - Biodegradable and
Non-biodegradable - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 122: Europe Historic Review for Implantable Drug Delivery
Devices by Type - Biodegradable and Non-biodegradable Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 123: Europe 15-Year Perspective for Implantable Drug
Delivery Devices by Type - Percentage Breakdown of Value Sales
for Biodegradable and Non-biodegradable for the Years 2012,
2020 & 2027

Table 124: Europe Current & Future Analysis for Implantable
Drug Delivery Devices by Technology - Diffusion, Osmotic,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05960990/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001